- 抑制劑
- 化合物庫
- 抗體
- 生物試劑
- 新產(chǎn)品
- 聯(lián)系我們
別名: GSK2118436, GSK2118436A 中文名稱:達拉菲尼,達拉非尼
Dabrafenib是一種突變型BRAFV600E特異性抑制劑,無細胞試驗中IC50為0.7 nM,作用于B-Raf(wt)和c-Raf效果分別低7和9倍。
Dabrafenib Chemical Structure
CAS: 1195765-45-7
規(guī)格 | 價格 | 庫存 | 購買數(shù)量 |
---|---|---|---|
10mM (1mL in DMSO) | 892.71 | 現(xiàn)貨 | |
5mg | 733.64 | 現(xiàn)貨 | |
20mg | 1394.46 | 現(xiàn)貨 | |
50mg | 2235.84 | 現(xiàn)貨 | |
100mg | 3261.37 | 現(xiàn)貨 | |
1g | 9582.3 | 現(xiàn)貨 | |
更大包裝 有超大折扣 | |||
400-668-6834 |
|||
細胞系 | 實驗類型 | 給藥濃度 | 孵育時間 | 活性描述 | 文獻信息 |
---|---|---|---|---|---|
HuNS-1 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
IGROV1 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
HT-3 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
HT | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
HPAF-II | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
Hs746.T | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
HOS | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
HN5 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
HMCB | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
Hep3B | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
Hela | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
HCC-1954 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
HCC-70 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
G401 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
FaDu | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
EKVX | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
EFM-19 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
EB-3 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
DU-145 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
DOTC 24510 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
Daudi | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
CRO-AP2 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
COR-L23 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
Colo704 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
Colo320DM | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
CHL-1 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
CGTHW1 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
CaOV3 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
Calu-3 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
CAL-62 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
CAL-27 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
C33A | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
C-4 I | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
BxPc3 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
BT-20 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
Be(2)C | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
ARH-77 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
A2780 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
A431 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
A427 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
A204 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
A172 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
786-O | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
647-V | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
22Rv1 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
MES-SA | Growth Inhibition Assay | 10 μM | 72 h | IC50=6.989 μM | 23844038 |
C3A | Growth Inhibition Assay | 10 μM | 72 h | IC50=5.414 μM | 23844038 |
HL-60 | Growth Inhibition Assay | 10 μM | 72 h | IC50=2.178 μM | 23844038 |
HT-1080 | Growth Inhibition Assay | 10 μM | 72 h | IC50=2.004 μM | 23844038 |
GDM-1 | Growth Inhibition Assay | 10 μM | 72 h | IC50=1.997 μM | 23844038 |
CEM/C1 | Growth Inhibition Assay | 10 μM | 72 h | IC50=1.773 μM | 23844038 |
SNU-1 | Growth Inhibition Assay | 10 μM | 72 h | IC50=1.501 μM | 23844038 |
MC/CAR | Growth Inhibition Assay | 10 μM | 72 h | IC50=1.002 μM | 23844038 |
RPMI-6666 | Growth Inhibition Assay | 10 μM | 72 h | IC50=928 nM | 23844038 |
DB | Growth Inhibition Assay | 10 μM | 72 h | IC50=873 nM | 23844038 |
BC-1 | Growth Inhibition Assay | 10 μM | 72 h | IC50=704 nM | 23844038 |
H4 | Growth Inhibition Assay | 10 μM | 72 h | IC50=619 nM | 23844038 |
CESS | Growth Inhibition Assay | 10 μM | 72 h | IC50=497 nM | 23844038 |
SK-MES-1 | Growth Inhibition Assay | 10 μM | 72 h | IC50=329 nM | 23844038 |
JRT3-T35 | Growth Inhibition Assay | 10 μM | 72 h | IC50=295 nM | 23844038 |
ACHN | Growth Inhibition Assay | 10 μM | 72 h | IC50=294 nM | 23844038 |
BC-3 | Growth Inhibition Assay | 10 μM | 72 h | IC50=277 nM | 23844038 |
RPMI-8226 | Growth Inhibition Assay | 10 μM | 72 h | IC50=263 nM | 23844038 |
HuT78 | Growth Inhibition Assay | 10 μM | 72 h | IC50=52 nM | 23844038 |
BFTC-905 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
SK-N-AS | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
CHP-212 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
LS1034 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
HCC-2998 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
Calu-6 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
NCI-H460 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
T-84 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
NCI-H747 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
HCT-116 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
DLD-1 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
SW480 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
SHP-77 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
A549 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
LS-174T | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
UMUC-3 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
SW-837 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
SW756 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
MDA-MB-231 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
NCI-H508 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
OV-90 | Growth Inhibition Assay | 10 μM | 72 h | IC50=29 nM | 23844038 |
YUMAC | Growth Inhibition Assay | 10 μM | 72 h | IC50=5 nM | 23844038 |
WM-115 | Growth Inhibition Assay | 10 μM | 72 h | IC50=5 nM | 23844038 |
GCT | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
A673 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
RKO | Growth Inhibition Assay | 10 μM | 72 h | IC50=2.522 μM | 23844038 |
SW872 | Growth Inhibition Assay | 10 μM | 72 h | IC50=377 nM | 23844038 |
SW1417 | Growth Inhibition Assay | 10 μM | 72 h | IC50=158 nM | 23844038 |
HT-29 | Growth Inhibition Assay | 10 μM | 72 h | IC50=66 nM | 23844038 |
ES-2 | Growth Inhibition Assay | 10 μM | 72 h | IC50=53 nM | 23844038 |
A101D | Growth Inhibition Assay | 10 μM | 72 h | IC50=9 nM | 23844038 |
SH-4 | Growth Inhibition Assay | 10 μM | 72 h | IC50=8 nM | 23844038 |
SK-MEL-3 | Growth Inhibition Assay | 10 μM | 72 h | IC50=7 nM | 23844038 |
Colo 205 | Growth Inhibition Assay | 10 μM | 72 h | IC50=7 nM | 23844038 |
UACC-257 | Growth Inhibition Assay | 10 μM | 72 h | IC50=6 nM | 23844038 |
DU-4475 | Growth Inhibition Assay | 10 μM | 72 h | IC50=5 nM | 23844038 |
A375 | Growth Inhibition Assay | 10 μM | 72 h | IC50=4 nM | 23844038 |
SK-MEL-28 | Growth Inhibition Assay | 10 μM | 72 h | IC50=3 nM | 23844038 |
M14 | Growth Inhibition Assay | 10 μM | 72 h | IC50=2 nM | 23844038 |
SK-MEL-1 | Growth Inhibition Assay | 10 μM | 72 h | IC50=2 nM | 23844038 |
C32TG | Growth Inhibition Assay | 10 μM | 72 h | IC50=1 nM | 23844038 |
UACC-62 | Growth Inhibition Assay | 10 μM | 72 h | IC50=1 nM | 23844038 |
MALME-3M | Growth Inhibition Assay | 10 μM | 72 h | IC50=1 nM | 23844038 |
A375P-F11 | Growth Inhibition Assay | 10 μM | 72 h | Inhibition of B-Raf V600E mutant-driven A375P-F11 cell proliferation with IC50 of 0.071 μM | 23844038 |
SK-MEL-28 | Growth Inhibition Assay | 10 μM | 72 h | Inhibition of B-Raf V600E mutant-driven SK-MEL-28 cell proliferation with IC50 of 0.043 μM | 23844038 |
HFF | Growth Inhibition Assay | 10 μM | 72 h | Inhibition of proliferation of human HFF cells harboring wild type B-Raf with IC50 of 3 μM | 24900673 |
J82 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
JM1 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
Kato III | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
KHOS-240S | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
KM-12 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
KPL-1 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
KYSE-30 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
LNCaP | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
MCF-7 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
MC-IXC | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
MDA-MB-175 VII | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
MDA-MB-468 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
MiaPaCa | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
Molt-4 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
NCI-ADR/RES | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
NCI-H69 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
NCI-H82 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
NCI-N87 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
NCI-H146 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
NCI-H157 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
NCI-H187 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
NCI-H209 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
NCI-H226 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
NCI-H292 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
NCI-H322 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
NCI-H358 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
NCI-H520 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
NCI-H526 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
NCI-H630 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
NCI-H661 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
NCI-H716 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
NCI-H1563 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
NCI-H1792 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
NCI-H2030 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
NCI-H2052 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
NCI-H2122 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
NCI-H2228 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
OE-19 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
OE-21 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
OE-33 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
OVCAR-3 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
OVCAR-4 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
OVCAR-5 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
P3HR-1 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
PC-3 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
Raji | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
RD | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
RD-ES | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
RL | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
SaOS2 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
SCC-9 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
SCC-12 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
SCC-13 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
SCC-15 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
SCC-25 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
SCLC-3 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
SF-268 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
SF-295 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
SJRH30 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
SK-BR-3 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
SK-LMS-1 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
SK-N-DZ | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
SK-N-F1 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
SKOV-3 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
SK-UT-1 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
SN12C | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
SNB-19 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
SNU-5 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
SNU-16 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
SNU-398 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
SNU-449 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
SR | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
ST486 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
SW579 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
SW684 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
SW-780 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
SW900 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
SW1088 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
SW1463 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
SW1990 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
T47D | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
TE381.T | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
TK-10 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
U2OS | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
U251 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
UACC-812 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
YAPC | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
ZR-75-1 | Growth Inhibition Assay | 10 μM | 72 h | IC50=10 μM | 23844038 |
A375 | Function assay | 1.2 μM | 4 h | Inhibition of phosphorylation of MEK, ERK, and S6P | 22389471 |
Colo-205 | Function assay | 1 μM | 4 d | Induced a highly comparable compaction phenotype | 25381152 |
M257 | Growth Inhibition Assay | 100 nM | 72 h | Does not inhibit proliferation of M257 cell harbouring wild type BRAF | 23317446 |
LCP | Growth Inhibition Assay | 100 nM | 72 h | Inhibition of proliferation of LCP cell harbouring BRAF V600R mutantation | 23317446 |
WM266 | Growth Inhibition Assay | 100 nM | 72 h | Inhibition of proliferation of WM266 cell harbouring BRAF V601D mutantation | 23317446 |
M257 | Growth Inhibition Assay | 100 nM | 72 h | Does not inhibit ERK1-2 phosphorylation in M257 cell harbouring wild type BRAF | 23317446 |
LCP | Growth Inhibition Assay | 100 nM | 72 h | Inhibit ERK1-2 phosphorylation in LCP cell harbouring BRAF V600R mutantation | 23317446 |
WM266 | Growth Inhibition Assay | 100 nM | 72 h | Inhibit ERK1-2 phosphorylation in WM266 cell harbouring BRAF V600D mutantation | 23317446 |
RBW-1 | Function assay | 1 μM | No reduction of Mek 1/2 phosphorylation | 24885690 | |
RBO-1 | Function assay | 1 μM | Inhibition of Mek 1/2 phosphorylation | 24885690 | |
RBO-2 | Function assay | 1 μM | Inhibition of Mek 1/2 phosphorylation | 24885690 | |
RBOW | Function assay | 1 μM | Inhibition of Mek 1/2 phosphorylation | 24885690 | |
HepG2 | Function Assay | 45 min | Inhibition of Alk5 in TGF-beta-stimulated human HepG2 cells assessed as decrease in Smad2 phosphorylation treated for 45 mins prior to TGF-beta stimulation measured after 60 mins by odyssey blot scanner analysis with IC50 of 3.7 μM | 24900673 | |
SK-MEL-28 | Kinase Assay | 1 h | Inhibition of B-Raf V600E mutant in human SK-MEL-28 cells assessed as decrease in ERK phosphorylation with IC50 of 0.004 μM | 24900673 | |
A375 | BRAF competitive binding assay | 15 min | IC50 = 0.006 μM | 25965804 | |
A375 | Function assay | 72 h | IC50 = 0.011 μM | 25965804 | |
A375 | ARAF competitive binding assay | 15 min | IC50 = 0.026 μM | 25965804 | |
A375 | CRAF competitive binding assay | 15 min | IC50 = 0.15 μM | 25965804 | |
A375 | Function assay | 1 h | IC50 = 0.001 μM | 27085672 | |
MIAPaCa2 | Function assay | 1 h | EC50 = 0.529 μM | 27085672 | |
SK-MEL-28 | Cytotoxicity assay | 72 h | IC50 = 0.043 μM | 29461827 | |
Sf9 | Function assay | 60 min | IC50 = 0.009 μM | 27774137 | |
SK-MEL-28 | Growth inhibition assay | 48 h | Growth inhibition of human SK-MEL-28 cells harboring BRAF V600E mutant measured after 48 hrs resazurin assay | 27774137 | |
SK-MEL-28 | Growth inhibition assay | 48 h | Growth inhibition of human SK-MEL-28 cells harboring BRAF V600E mutant preincubated for 1 hr followed by irradiation of 1.13 kW/m2 UV-light for 5 mins measured after 48 hrs resazurin assay | 27774137 | |
SK-MEL-28 | Cytotoxicity assay | 48 h | Cytostatic activity in human SK-MEL-28 cells harboring BRAF V600E mutant at 1 and 30 uM measured after 48 hrs resazurin assay | 27774137 | |
COLO205 | Growth Inhibition Assay | Inhibition of human COLO205 cell proliferation with IC50 of 0.007 μM | 24900673 | ||
HepG2 | Kinase Assay | Inhibition of B-Raf V600E mutant in human HepG2 cells assessed as decrease in ERK phosphorylation with IC50 of 0.004 μM | 24900673 | ||
Kinase Assay | Inhibition of N-terminal His tagged B-Raf V600E mutant expressed in baculovirus infected insect cells co-expressing CDC37 assessed as decrease in biotinylated-MEK protein phosphorylation by AlphaScreen assay with IC50 of 0.0007 μM | 24900673 | |||
YUSIT1 | Function assay | reduced sensitivity with IC50 > 0.5 μM | 22389471 | ||
MeWo | Growth inhibition assay | IC50 = 987 nM | 26018524 | ||
WiDr | Growth inhibition assay | IC50 = 76 nM | 26018524 | ||
HCT116 | Function assay | IC50 = 5.88 μM | 25965804 | ||
A375 | Function assay | IC50 = 0.004 μM | 29461827 | ||
DAOY | Primary screen assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for DAOY cells | 29435139 | ||
NB1643 | Primary screen assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB1643 cells | 29435139 | ||
SK-N-MC | Primary screen assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-MC cells | 29435139 | ||
點擊查看更多細胞系數(shù)據(jù) |
產(chǎn)品描述 | Dabrafenib是一種突變型BRAFV600E特異性抑制劑,無細胞試驗中IC50為0.7 nM,作用于B-Raf(wt)和c-Raf效果分別低7和9倍。 | ||||||
---|---|---|---|---|---|---|---|
靶點 |
|
體外研究(In Vitro) | ||||
體外研究活性 | Dabrafenib對Raf激酶具有選擇性,對B-Raf的活性比其它測試過的91%的激酶高400倍。 Dabrafenib抑制B-RafV600E激酶,導(dǎo)致ERK磷酸化降低和抑制細胞的增值,在特異性編碼突變的B-RafV600E的癌細胞中細胞停滯在G1期。 |
|||
---|---|---|---|---|
實驗圖片 | 檢測方法 | 檢測指標 | 實驗圖片 | PMID |
Western blot | pMEK / pERK / ERK p-S6 / p-AKT308 / p-AKT473 β-catenin |
![]() |
31158244 | |
Growth inhibition assay | IC50 |
![]() |
24735930 |
體內(nèi)研究(In Vivo) | ||
體內(nèi)研究活性 | Dabrafenib(口服)抑制B-RafV600E突變的黑色素瘤(A375P)的生長,在免疫受損小鼠中皮下注射結(jié)腸癌(Colo205),Dabrafenib(口服)同樣能抑制腫瘤生長。 [1] |
---|
NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
---|---|---|---|---|---|
NCT06079333 | Recruiting | Anaplastic Thyroid Cancer |
Leiden University Medical Center|Novartis |
January 1 2023 | Phase 2 |
NCT06337617 | Completed | BRAF V600 Mutation Positive Melanoma |
Novartis Pharmaceuticals|Novartis |
May 10 2022 | -- |
NCT04961619 | Recruiting | Melanoma |
Novartis Pharmaceuticals|Novartis |
December 1 2021 | -- |
NCT04547946 | Completed | Malignant Melanoma |
Novartis Pharmaceuticals|Novartis |
October 15 2021 | -- |
NCT05171374 | Recruiting | Melanoma Stage III|Melanoma Stage IV|Melanoma |
MelanomaPRO Russia|Novartis |
September 30 2021 | -- |
分子量 | 519.56 | 分子式 | C23H20F3N5O2S2 |
CAS號 | 1195765-45-7 | SDF | Download Dabrafenib SDF |
Smiles | CC(C)(C)C1=NC(=C(S1)C2=NC(=NC=C2)N)C3=C(C(=CC=C3)NS(=O)(=O)C4=C(C=CC=C4F)F)F | ||
儲存條件(自收到貨起) | |||
體外溶解度 |
DMSO : 100 mg/mL ( (192.47 mM) ;DMSO吸濕會降低化合物溶解度,請使用新開封DMSO) Water : Insoluble Ethanol : Insoluble |
摩爾濃度計算器 |
體內(nèi)溶解度 現(xiàn)配現(xiàn)用,請按從左到右的順序依次添加,澄清后再加入下一溶劑 |
動物體內(nèi)配方計算器 |
動物體內(nèi)配方計算器(澄清溶液)
第一步:請輸入基本實驗信息(考慮到實驗過程中的損耗,建議多配一只動物的藥量)
第二步:請輸入動物體內(nèi)配方組成(配方適用于不溶于水的藥物;不同批次藥物配方比例不同,請聯(lián)系Selleck為您提供正確的澄清溶液配方)
計算結(jié)果:
工作液濃度: mg/ml;
DMSO母液配制方法: mg 藥物溶于μL DMSO溶液(母液濃度mg/mL,注:如該濃度超過該批次藥物DMSO溶解度,請先聯(lián)系Selleck);
體內(nèi)配方配制方法:取μL DMSO母液,加入μL PEG300,混勻澄清后加入μL Tween 80,混勻澄清后加入μL ddH2O,混勻澄清。
體內(nèi)配方配制方法:取μL DMSO母液,加入μL Corn oil,混勻澄清。
注意:1. 首先保證母液是澄清的;
2.一定要按照順序依次將溶劑加入,進行下一步操作之前必須保證上一步操作得到的是澄清的溶液,可采用渦旋、超聲或水浴加熱等物理方法助溶。
在訂購、運輸、儲存和使用我們的產(chǎn)品的任何階段,您遇到的任何問題,均可以通過撥打我們的熱線電話400-668-6834,或者技術(shù)支持郵箱tech@selleck.cn,直接聯(lián)系到我們。我們會在24小時內(nèi)盡快聯(lián)系您。
如果有其他問題,請給我們留言。
* 必填項